Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

NCT00657982 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: RAD001

Sponsor

Sheba Medical Center